Comparing severe outcome risks of SARS-CoV-2 Omicron BA.2.75, BQ.1, BA.4.6 to BA.5

Researchers determine the clinical severity of SARS-CoV-2 Omicron sub-lineages BA.4.6, BQ.1, and BA.2.75 relative to BA.5.